News from janssen A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

06 Jun, 2012, 08:00 BST New Five Year Data for STELARA®▼ (Ustekinumab) Show Consistent Efficacy and Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis

Findings from a psoriasis clinical development programme for a biologic following patients continuously for five years provide insights on the...


02 Jun, 2012, 05:01 BST ZYTIGA® Plus Prednisone Show Improvements in Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer

Note: Data in this release correspond to ASCO Abstract LBA 4518. Phase III Results Show Significant Improvement in Radiographic Progression-Free...


20 May, 2012, 16:13 BST Les données de ZYTIGA® (acétate d'abiratérone) seront présentées lors de l'Assemblée annuelle 2012 de l'American Society of Clinical Oncology (ASCO)

 Remarque : ce communiqué correspond aux résumés cliniques LBA 4518, 4521, 4556 et 4558 de l'ASCO. Les données liées aux études cliniques de ZYTIGA® ...


18 May, 2012, 14:04 BST ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting

Note: This release corresponds to ASCO abstracts LBA 4518, 4521, 4556 and 4558. Data related to ZYTIGA® (abiraterone acetate) clinical studies have...


19 Apr, 2012, 11:50 BST Janssen's Commitment to People with Hepatitis C

As the European Association for the Study of the Liver (EASL) International Liver Congress™ 2012 opens in Barcelona, Janssen Pharmaceutical Companies ...


19 Apr, 2012, 07:00 BST Janssen Creates new Division to Launch TMC435 and Help Conquer Hepatitis C in EMEA

Today sees the launch of Janssen Therapeutics EMEA, a division of Janssen Pharmaceutica NV, dedicated to bringing the investigational protease...


01 Mar, 2012, 11:06 GMT Report by the Economist Intelligence Unit Gives High Level Picture of the Continent's Healthcare Challenges

"The Future Of Healthcare In Africa" By 2022 reformed healthcare systems in African countries could succeed in making quality care available to a...


21 Oct, 2011, 12:21 BST STELARA® (ustekinumab)is Effective, Well-Tolerated and Improves Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis Inadequately Responsive to Methotrexate[1,2]

New Data Presented at EADV New findings from the TRANSIT study were presented today at the 20th European Academy of Dermatology and Venereology...


07 Sep, 2011, 09:00 BST Zytiga® Approved in the European Union for Metastatic Castration-Resistant Prostate Cancer

First once-daily, oral treatment inhibits androgen production at all sources Janssen-Cilag International NV announced today that, after an...


22 Jul, 2011, 15:58 BST Zytiga® Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic Castration Resistant Prostate Cancer

Janssen-Cilag International NV announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA)...


06 Jun, 2011, 16:45 BST DACOGEN(R) (decitabine) Showed an Overall Survival Advantage Compared With the Accepted Standard Therapies in Older Patients With Newly Diagnosed De Novo or Secondary Acute Myeloid Leukemia

- Data From DACO-016 Trial at 2011 American Society of Clinical Oncology Annual Meeting - NB: Data in this release corresponds to ASCO abstract 6504...


24 May, 2011, 08:00 BST Schizophrenia24x7.com: A New, Interactive Website for Patients and Carers

- To view a short video about Schizophrenia24x7 please visit: http://www.brainshark.com/janssencns/Schizophrenia24x7 Schizophrenia24x7.com is a new,...


18 May, 2011, 08:00 BST Schizophrenia24x7.com: A New, Interactive Website for Patients and Carers

Schizophrenia24x7.com is a new, interactive website featuring helpful resources, information and interactive tools for people affected by...


31 Mar, 2011, 17:00 BST Auf Telaprevir basierende Behandlung ist im Vergleich zur Standardbehandlung bei Hepatitis C-Patienten nachweislich bedeutend wirksamer

- Phase-3-REALIZE-Studiendaten bei EASL präsentiert Tibotec Virco-Virology BVBA gab heute bekannt, dass eine bedeutend höhere Anzahl an Patienten,...


31 Mar, 2011, 17:00 BST Auf Telaprevir basierende Behandlung ist im Vergleich zur Standardbehandlung bei Hepatitis C-Patienten nachweislich bedeutend wirksamer

- Phase-3-REALIZE-Studiendaten bei EASL präsentiert Tibotec Virco-Virology BVBA gab heute bekannt, dass - im Vergleich zur derzeitigen...


31 Mar, 2011, 17:00 BST New Data Shows 83% of Patients With Genotype 1 Hepatitis C, Who Have Previously Relapsed on Existing Standard of Care Treatments, Achieve a Cure With Investigational Agent Telaprevir[1]

Janssen Pharmaceutical Companies of Johnson & Johnson* is today announcing, at the 46th Annual Meeting of the European Association for the Study...


09 Mar, 2011, 08:00 GMT European Commission Approves XEPLION(R) for Treatment of Schizophrenia

Janssen-Cilag International NV today announced that XEPLION(R) (paliperidone palmitate), a once monthly, long-acting injectable, antipsychotic, has...


04 Jan, 2011, 08:00 GMT INVEGA(R) Approved as First and Only Antipsychotic Treatment for Schizoaffective Disorder in the European Union

Janssen-Cilag International NV today announced that it has received approval from the European Commission for the first antipsychotic treatment for...